ARII up +3.11% percent right now. $ARII High is at 69.35

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 12:59 PM

ARII up +3.11% percent right now. $ARII High is at 69.35 and the Low 67.27 with current volume of 121,390.

Recent News posted below.

ARII American Railcar Industries Recent Headline News

Railcar Demand Defies Oil Slide: 4 Stock Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Nov 07, 9:22AM CST
The demand for railroad tank-car orders continues to grow despite the decline in oil prices.
ARII: 68.38 (+2.10), GMT: 65.48 (+0.37), GBX: 61.27 (+1.36), TRN: 35.72 (+0.02)

American Railcar beats 3Q profit forecasts
Automated Insights - Thu Oct 30, 4:03AM CDT
ST. CHARLES, Mo. (AP) _ American Railcar Industries Inc. (ARII) on Thursday reported third-quarter earnings of $23.8 million.
ARII: 68.38 (+2.10)

American Railcar Industries, Inc. Reports Third Quarter Results
GlobeNewswire - Wed Oct 29, 4:38PM CDT
Third Quarter 2014 Highlights
ARII: 68.38 (+2.10)

Surprising Stocks That Performed Best for Billionaires in 2014
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the best for 19 billionaires who made their money investing.
BDSI: 16.19 (+0.69), ATHL: 58.39 (+0.05), VIPS: 24.47 (+1.13), ARII: 68.38 (+2.10), SBAC: 113.17 (-1.45), BIOF: 7.28 (+0.01), BKW: 32.23 (-0.37), LUV: 38.86 (+0.62), HCA: 67.27 (+1.52), LPDX: 5.22 (-0.01), DTV: 87.61 (+0.21), RCPT: 109.14 (-0.10), WMB: 55.40 (+0.02), BRK.B: 144.56 (+0.95), BRK.A: 216,876.22 (+1,906.22), SBGL: 6.69 (-0.47), AN: 57.45 (-0.14)

The Zacks Analyst Blog Highlights: JetBlue Airways, United Continental Holdings, Delta Air Lines, American Railcar Industries and Covenant Transportation Group
PR Newswire - Thu Oct 23, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the JetBlue Airways Corp. (Nasdaq:JBLU-Free Report), United Continental Holdings, Inc. (NYSE:UAL-Free Report), Delta Air Lines, Inc. (NYSE

AL-Free Report), American Railcar Industries, Inc. (Nasdaq:ARII-Free Report) and Covenant Transportation Group, Inc. (Nasdaq:CVTI-Free Report).
ARII: 68.38 (+2.10), UAL: 54.83 (+0.65)

Ryder System Earnings in Line, Maintains Guidance (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 3:46PM CDT
The company registered revenues of $1,687.2 million in the third quarter, up 3.2% year over year but below the Zacks Consensus Estimate of $1,717 million.
ARII: 68.38 (+2.10), FLY: 12.67 (-0.09), R: 92.94 (+1.48), AYR: 20.25 (+0.06)

3 Transportation Stocks to Buy Now - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Oct 22, 12:27PM CDT
The most impressive rally in transportation stocks since 2011 has been helping US equity markets rebound.
ARII: 68.38 (+2.10), NSC: 115.97 (+3.11), DAL: 43.00 (+0.31), JBLU: 12.93 (+0.37), CVTI: 22.17 (+0.73), UAL: 54.83 (+0.65), LUV: 38.86 (+0.62)

Ryder System Earnings in Line, Q4 Outlook Slashed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 9:43AM CDT
Ryder System Inc. (R) reported third quarter 2014 earnings where the bottom line was at par with the Zacks Consensus Estimate.
ARII: 68.38 (+2.10), FLY: 12.67 (-0.09), R: 92.94 (+1.48), AYR: 20.25 (+0.06)

Trinity Industries Inc. (TRN) in Focus: Stock Jumps 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 8:18AM CDT
Trinity Industries Inc. (TRN) was a big mover last session, as the company saw its shares rise by over 8% on the day.
ARII: 68.38 (+2.10), GBX: 61.27 (+1.36), TRN: 35.72 (+0.02), AYR: 20.25 (+0.06)

Indexes Ease From Highs As Airlines Soar
at Investor's Business Daily - Fri Oct 17, 12:27PM CDT
Airlines and railcar makers rallied as stocks held the bulk of their gains in early-afternoon trade. The Dow led with a 1.6% gain, while the S&P 500 and Nasdaq were up 1.6% and 1.3%, respectively. Volume was tracking lower across the board in the...
ARII: 68.38 (+2.10), SAVE: 78.77 (+1.46), GBX: 61.27 (+1.36), DAL: 43.00 (+0.31), TRN: 35.72 (+0.02)

American Railcar Industries, Inc. Announces Third Quarter Financial Results Conference Call
GlobeNewswire - Thu Oct 16, 5:04PM CDT
American Railcar Industries, Inc. (Nasdaq:ARII) ("ARI" or the "Company"

announced today it will host a conference call on October 30, 2014 at 10:00 am (Eastern Time) to report the Company's third quarter financial results. The Company expects to release its financial results after the close of business on October 29, 2014 and these results will be available on the Investor Relations page at www.americanrailcar.com.
ARII: 68.38 (+2.10)

American Railcar Industries Has Returned 21.4% Since SmarTrend Recommendation (ARII)
Comtex SmarTrend(R) - Wed Oct 15, 9:54AM CDT
SmarTrend identified a Downtrend for American Railcar Industries (NASDAQ:ARII) on September 15th, 2014 at $74.68. In approximately 1 month, American Railcar Industries has returned 21.40% as of today's recent price of $58.70.
ARII: 68.38 (+2.10)

American Railcar Industries Shares Down 14.0% Since SmarTrend's Sell Call (ARII)
Comtex SmarTrend(R) - Wed Oct 08, 9:25AM CDT
SmarTrend identified a Downtrend for American Railcar Industries (NASDAQ:ARII) on September 15th, 2014 at $74.68. In approximately 3 weeks, American Railcar Industries has returned 14.05% as of today's recent price of $64.19.
ARII: 68.38 (+2.10)

Stocks Sell Off Amid Europe Woes, Mixed U.S. Data
at Investor's Business Daily - Wed Oct 01, 3:25PM CDT
Stocks sold off hard Wednesday, sparked by concerns about economic weakness in Europe and mixed U.S. economic data. The Nasdaq plunged 1.6%, while the Dow industrials sank 1.4% and the S&P 500 lost 1.3%. Volume rose across the board in the stock...
AYI: 139.95 (-0.44), ARII: 68.38 (+2.10), SWKS: 60.66 (+0.78), GBX: 61.27 (+1.36), TRN: 35.72 (+0.02), RGLD: 63.10 (-2.32), WAB: 89.52 (+0.25)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
AGII: 55.04 (-0.35), ARII: 68.38 (+2.10), ABTL: 9.98 (+0.08), BAS: 11.77 (-0.36), ALGT: 135.60 (+0.95)

American Railcar Industries, Inc. Names Jeffrey S. Hollister President and CEO and Umesh Choksi Senior Vice President, CFO and Treasurer
GlobeNewswire - Wed Sep 24, 4:23PM CDT
American Railcar Industries, Inc. (Nasdaq:ARII) ("ARI" or the "Company"

announced today that ARI's Board of Directors has appointed Jeffrey S. Hollister as the Company's President and Chief Executive Officer. The Board of Directors had appointed Mr. Hollister as President and Interim Chief Executive Officer on October 9, 2013.
ARII: 68.38 (+2.10)

'Mad Money' Lightning Round: Transocean Is a House of Pain
at The Street - Tue Sep 23, 5:00AM CDT
Cramer says Medivation is for real, he is sticking with Exact Sciences but General Electric is hard to own.
MDVN: 109.88 (-2.89), RH: 77.13 (-0.47), NSC: 115.97 (+3.11), GE: 26.48 (+0.07), ARII: 68.38 (+2.10), RIG: 29.58 (-0.13), GBX: 61.27 (+1.36), TRN: 35.72 (+0.02), EOG: 99.42 (-0.13), EXAS: 22.52 (-0.30), ANR: 2.64 (-0.27), UNP: 120.94 (+2.19)

Jim Cramer's 'Mad Money' Recap: An Unsettling Market Decline
at The Street - Mon Sep 22, 7:21PM CDT
But as far as Cramer's concerned, it's still business as usual.
RH: 77.13 (-0.47), GPRO: 76.18 (-2.88), NSC: 115.97 (+3.11), ARII: 68.38 (+2.10), GE: 26.48 (+0.07), EMES: 82.32 (-0.92), CLX: 101.21 (+0.42), GBX: 61.27 (+1.36), HCLP: 44.32 (+0.40), EXAS: 22.52 (-0.30), ANR: 2.64 (-0.27), MDVN: 109.88 (-2.89), V: 249.52 (-2.91), RIG: 29.58 (-0.13), TRN: 35.72 (+0.02), EOG: 99.42 (-0.13), MBLY: 46.30 (-0.47), AAPL: 109.02 (+0.01), UNP: 120.94 (+2.19), SLCA: 42.50 (-0.67), MA: 84.71 (-0.09), BABA: 117.10 (+2.54)

Market Indexes Rally Ahead Of Fed Statement
at Investor's Business Daily - Tue Sep 16, 3:30PM CDT
Stocks shrugged off early weakness and extended their gains through the session to close near session highs ahead of Wednesday's Federal Reserve statement. The Nasdaq and S&P 500 each closed up nearly 0.8%, while the Dow industrials, which hit a new...
TSLA: 241.51 (+1.31), ARII: 68.38 (+2.10), CNW: 46.16 (+0.73), GBX: 61.27 (+1.36), TRN: 35.72 (+0.02), WAB: 89.52 (+0.25)

American Railcar Industries Up 21.7% Since SmarTrend Uptrend Call (ARII)
Comtex SmarTrend(R) - Mon Sep 15, 9:16AM CDT
SmarTrend identified an Uptrend for American Railcar Industries (NASDAQ:ARII) on May 13th, 2014 at $61.88. In approximately 4 months, American Railcar Industries has returned 21.67% as of today's recent price of $75.29.
ARII: 68.38 (+2.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...